WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
SHANGHAI, China, and ST. PAUL, Minn., Jan. 3 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China’s premier provider of pharmaceutical R&D outsourcing services, has signed a definitive agreement to acquire US-based AppTec Laboratory Services, Inc. (AppTec). The acquisition of AppTec allows ...
WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
SHANGHAI, China, Jan. 3 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China’s premier provider of pharmaceutical R&D outsourcing services is pleased to announce today that it has promoted Mr. Edward Hu from Executive Vice President of Operations to Chief Operating Officer. Prior to j...
WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
SHANGHAI, China, Dec. 30 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services, sadly announced today one of its independent directors, Mr. Shawn Wang, Chief Financial Officer of Baidu, passed away in an accident during ...
Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
SHANGHAI, China, Dec. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today that Governor Deval L. Patrick of the Commonwealth of Massachusetts, accompanied by other members of Massachusetts China Partnership...
WuXi PharmaTech Announces Third Quarter 2007 Results
Third Quarter 2007 Net Income Grows 205% Year-Over-Year SHANGHAI, China, Nov. 12 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today a...
WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
Earnings Conference Call to be held on November 13, 2007 at 8:00 am (Eastern) / 5:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong) SHANGHAI, China, Oct. 24 /Xinhua-PRNewswire/ -— WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutic...
WuXi PharmaTech Holds the Groundbreaking Ceremony for its GLP Center in Suzhou
SHANGHAI, China, Oct. 9 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced that its future GLP center in Suzhou started construction on September 29, 2007. (Logo: http://www.prnasia.com/sa/200708281726-min.jpg )...
WuXi PharmaTech Announces Second Quarter 2007 Results
- Net Revenues Up 99% Year-Over-Year SHANGHAI, China, Sept. 5 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudi...
WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
Earnings Conference Call to be Held on September 6, 2007 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong) SHANGHAI, China, Sept. 4 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or “the Company”), the leading China-based pharmaceutical...
WuXi PharmaTech CEO Appointed to CrossFire Beilstein Database Advisory Board
SHANGHAI, China, Aug. 24 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today Dr. Ge Li, the Company's Chairman and Chief Executive Officer, is appointed to a newly established advisory board of Elsevier Informatio...
WuXi PharmaTech Announces Closing of Initial Public Offering
SHANGHAI, China, Aug. 14 /Xinhua-PRENewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company in the growing global drug R&D outsourcing market, announced today the closing of i...
WuXi PharmaTech (NYSE: WX) Fills Three Senior Level Positions
SHANGHAI, China, Aug. 13 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today the addition of three key senior level positions. These positions include Executive Vice President of Operations, Vice President o...
WuXi PharmaTech (Cayman) Inc. Announces Pricing of Initial Public Offering on NYSE
SHANGHAI, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) (“WuXi PharmaTech”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company in the growing global drug R&D outsourcing market, announced today that i...
WuXi PharmaTech Appoints Deepak Hegde as VP of Formulation
SHANGHAI, China, July 24 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China’s leading supplier of pharmaceutical R&D outsourcing services announced today the appointment of Dr. Deepak Hegde as Vice President of Formulation Development Services. (Logo: http://www.prnasia.com/sa/200611271812.jpg...
WuXi PharmaTech Sets Up Life Science and Chemistry Award
SHANGHAI, China, April 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical outsourcing services is pleased to announce the establishment of the "WuXi PharmaTech Life Science and Chemistry Award"; worth one million RMB. The award will honor individuals and gr...
WuXi PharmaTech Installs Supercritical Fluid Chromatography System
SHANGHAI, China, March 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has purchased and successfully brought online a Berger Supercritical Fluid Chromatography (SFC) MultiGram(R)III preparative system. ...
WuXi PharmaTech CEO Honored with 2006 China Top Ten Talents (Science & Technology) Award
SHANGHAI, China, Feb. 13 /Xinhua-PRNewswire/ -- Dr. Ge Li, Chairman and CEO of WuXi PharmaTech-China’s leading pharmaceutical R&D service company-received the “2006 Top Ten Talents (Science & Technology) in China” Award. This prestigious award was presented to Dr. Li and 9 other top scientific ...
WuXi PharmaTech Kicks off this Year’s Science Seminar Series by Welcoming Dr. Edward J.J. Grabowski
SHANGHAI, China, Feb. 5 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services started its 2007 Science Seminar Series off on a big step by welcoming Dr. Edward J.J Grabowski. Dr. Grabowski, retired VP of Chemistry (Process Research) at the M...
WuXi PharmaTech Starts Moving Scientists to New Facility
SHANGHAI, China, Jan. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has begun moving the first group of scientists to its state-of-the-art Tianjin research facility, which first became operational in De...
WuXi PharmaTech Listed Among Asia’s Fastest Growing Companies,Third Year Running
SHANGHAI, China, Dec. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China’s leading provider of pharmaceutical R&D outsourcing services announced today that it has been named 173rd on the Deloitte Technology Fast 500 Asia Pacific 2006 ranking. This is the third consecutive year the phar...
